Number of the records: 1
abatacept
Record number d000069594 Date 06.06.2025 Type M - MESH Topical term abatacept Other term Slovak (Pseudonym) belatacept
Slovak (Pseudonym) imunokonjugát CTLA4-Ig
Slovak (Pseudonym) antigén-4-imunoglobulín spojený s cytotoxickými T lymfocytmi
Slovak (Pseudonym) antigén-4-imunoglobulín asociovaný s cytotoxickými T lymfocytmi
Slovak (Pseudonym) CTLA4Ig
Slovak (Pseudonym) CTLA4-Fc
Slovak (Pseudonym) CTLA4-Ig imunokonjugát
Slovak (Pseudonym) molekula CTLA4-Ig, fúzovaná
Slovak (Pseudonym) Nulojix
Slovak (Pseudonym) belatacept
Slovak (Pseudonym) Orencia
Slovak (Pseudonym) antigén 4, asociovaný s cytotoxickými T lymfocytmi
See also (Later heading) antigén CTLA-4
(Skutočné meno) imunosupresíva
(Skutočné meno) antireumatiká
(Skutočné meno) inhibítory imunitných kontrolných bodov
(Skutočné meno) antigén CTLA-4
UDC D12.776.124.790.651.114.580.225D12.776.377.715.548.114.580.225 Note A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. 
subject heading
Number of the records: 1